Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration-Reference-Cited by-同舟云学术

Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration

Published:2024-06 Issue:6 Volume:21 Page:855-862
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Yamamoto Nobuhiko^ORCID,Noda Takashi,Nakano Makoto,Ito Tomohiro,Sato Hiroyuki,Hayashi Hideka,Chiba Takahiko,Hasebe Yuhi,Ueda Nobuhiko,Kamakura Tsukasa,Ishibashi Kohei,Miyata Satoshi,Kusano Kengo,Yasuda Satoshi

Publisher

Elsevier BV

Reference28 articles.

1. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure;Cleland;Eur Heart J,2013

2. Effects of cardiac resynchronization therapy on cardiac remodeling and contractile function: results from Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE);St John Sutton;J Am Heart Assoc,2015

3. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: implementation;Parkash;Can J Cardiol,2013

4. JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias;Nogami;Circ J,2022

5. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities;Epstein;Circulation,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dropping the floor on QRS duration boundaries for CRT patient selection in 2024—effects of sex, race, height, and heart size;Heart Rhythm;2024-06